A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa

Advances in nanotechnology have enabled the development of a new generation of vaccines, which are playing a critical role in the global control of the COVID-19 pandemic and the return to normalcy. Vaccine development has been conducted, by and large, by countries in the global north. South Africa, as a major emerging economy, has made extensive investments in nanotechnology and bioinformatics and has the expertise and resources in vaccine development and manufacturing. This has been built at a national level through decades of investment. In this perspective article, we provide a synopsis of the investments made in nanotechnology and highlight how these could support innovation, research, and development for vaccines for this disease. We also discuss the application of bioinformatics tools to support rapid and cost-effective vaccine development and make recommendations for future research and development in this area to support future health challenges.

Automated summary

South Africa, as a major emerging economy, has made extensive investments in nanotechnology and bioinformatics, leading to expertise and resources in vaccine development and manufacturing. Investments in these areas can support vaccine innovation, research, and development, offering support for future health challenges.